IUCT Oncopole; Hematologie
About IUCT Oncopole; Hematologie
"L'IUCT Oncopole est composé de l'Institut Claudius Regaud, centre de lutte contre le cancer et de plusieurs équipes du CHU de Toulouse. Sur un même site, les deux établissements réunissent l'expertise de 1500 professionnels spécialisés en cancérologie. L'Institut est situé au cœur d'un campus regroupant des acteurs privés et publics investis dans la lutte contre le cancer. Trois missions lui sont confiées : le soin, la recherche et l'enseignement."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at IUCT Oncopole; Hematologie
During the past decade, IUCT Oncopole; Hematologie conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on
average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
2015-12-30
2020-04-24
Terminated
447
Nivolumab With Gemcitabine, Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients
2017-12-05
2024-11-01
Recruiting
388
Study Impact on Outcome of Eltrombopag in Elderly Patients With Acute Myeloid Leukemia Receiving Induction Chemotherapy
2018-10-11
2024-09-01
Active, not recruiting
110
Dexamethasone Added to Intensive Chemotherapy in Older Patients With Acute Myeloid Leukemia (AML)
2018-08-24
2025-12-31
Active, not recruiting
120
Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction
2018-12-19
2026-06-01
Active, not recruiting
29
BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation
2019-07-05
2023-02-04
Active, not recruiting
41
Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia
2019-09-27
2026-06-01
Active, not recruiting
120
Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19
2020-03-14
2022-12-31
Recruiting
50
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "IUCT Oncopole; Hematologie"
#1 collaborator was "Acute Leukemia French Association" with 3 trials as a collaborator, "AbbVie" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were
collaborators in the rest 14 trials.
Clinical Trials Conditions at IUCT Oncopole; Hematologie
According to Clinical.Site data, the most researched conditions in "IUCT Oncopole; Hematologie" are
"Acute Myeloid Leukemia" (4 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloblastic Leukemia" (1 trials), "Bruton Tyrosine Kinase Inhibitor" (1 trials) and "CLL, Refractory" (1 trials). Many other conditions were trialed in "IUCT Oncopole; Hematologie" in a lesser frequency.
Clinical Trials Intervention Types at IUCT Oncopole; Hematologie
Most popular intervention types in "IUCT Oncopole; Hematologie" are "Drug" (12 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "ACA Continuation" (1 trials), "Blinatumomab" (1 trials), "CPX-351" (1 trials) and "Cytarabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IUCT Oncopole; Hematologie
The vast majority of trials in "IUCT Oncopole; Hematologie" are
15 trials for "All" genders.
Clinical Trials Status at IUCT Oncopole; Hematologie
Currently, there are NaN active trials in "IUCT Oncopole; Hematologie".
undefined are not yet recruiting,
8 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in IUCT Oncopole; Hematologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in IUCT Oncopole; Hematologie, 1 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".